Medicines and biologic therapies
Asteria develops, manufactures and commercializes specialty medicines and biologic therapies.
OUR COMPANY
How Asteria works.
Asteria BioHealth Group develops, manufactures and commercializes specialty medicines and biologic therapies.
OUR BUSINESS
A business built around connected responsibilities.
Established medicines help fund long research cycles, production capacity and selected scientific acquisitions.
Products. Alliances. Intellectual property.
Revenue comes from product sales, development/commercialization alliances, and intellectual-property licensing.
2025 COMPANY REFERENCE
The business, in perspective.
2025 full-year figures. Our Ireland feature returns to an earlier chapter in January.
$6.18 billion
2025 worldwide revenue.
$5.00 billion
2025 product revenue.
$980 million
2025 collaboration revenue.
$200 million
2025 licensing and royalty revenue.
THE GROUP
One parent. Distinct responsibilities.
Seven group entities
One parent and six wholly owned corporate subsidiaries make seven group entities after the Irish closing.
The role of the parent
The parent directs strategy, funds research, owns selected IP, manages alliances/licenses and treasury; it is not the seller of ordinary finished products to US customers.
The US commercial business
US commercial contracts with US product customers, invoices, collects receivables and administers rebates.
The company whose name you recognize is not always the company that invoices the customer. Every entity has a particular role.
Explore the group businessesThe domestic parent is publicly traded and SEC-reporting as of December 31, 2025.
THE VALUES THAT SPELL ASTERIA
Our values matter most when the answer isn’t obvious.
A — Ask better questions
Challenge assumptions. Listen to the people closest to the problem. Be willing to say, “We don’t know yet.”
S — Stay true to the science
Follow the evidence, especially when it challenges our preferred answer. Change our minds when the findings change.
T — Think together
Bring different disciplines in early. Share context, invite disagreement and make room for expertise beyond our own.
E — Earn trust
Say what we know, what we don’t and what we’ll do next. Keep commitments and speak up early when they’re at risk.
R — Remember who it’s for
Keep patients, families and the people who depend on our work in view. Ask what our decisions mean for them.
I — Imagine better
Look beyond the familiar approach. Turn promising ideas into questions we can test, and share what we learn.
A — Act with care
Consider the consequences, not just the immediate result. Protect safety and quality, raise concerns and take responsibility for putting things right.